Intestinal-specific marker may predict colorectal cancer metastases

Venook, Alan P.
October 2008
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p16
The article reports on the data presented by Scott A. Waldman, which showed that the presence of a specific protein in the lymph nodes could indicate metastatic disease in patients with colorectal cancer. The data presentation was made by Waldman at the Third International Conference on Molecular Diagnostics in Cancer Therapeutic Development of the American Association for Cancer Research in Philadelphia, Pennsylvania. His study focuses on the role of guanylyl cyclase in c (GCC) in colorectal cancers.


Related Articles

  • Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease Free Survival in pNO Colorectal Cancer. Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Barkun, Alan; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan; Weinberg, David S. // JAMA: Journal of the American Medical Association;2/18/2009, Vol. 301 Issue 7, p745 

    The article presents a study investigating guanylyl cyclase 2C (GUCY2C) as an indicator of metastasis in colorectal cancer. Some patients who seem free of metastasis to lymph nodes have a recurrence of cancer. The authors suggested that metastasis may be present, but undetected by testing. The...

  • Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells. Giovanni M. Pitari; Jieru E. Lin; Fawad J. Shah; Wilhelm J. Lubbe; David S. Zuzga; Peng Li; Stephanie Schulz; Scott A. Waldman // Carcinogenesis;Aug2008, Vol. 29 Issue 8, p1601 

    Guanylyl cyclase C (GCC), the receptor for diarrheagenic bacterial heat-stable enterotoxins (STs), inhibits colorectal cancer cell proliferation by co-opting Ca2+ as the intracellular messenger. Similarly, extracellular Ca2+ (Ca2+o) opposes proliferation and induces terminal differentiation in...

  • Breakthroughs reported in controlling colon cancer. Pfeiffer, Naomi // Drug Topics;6/19/2006, Vol. 150 Issue 12, pHSE2 

    The article highlights the two topics discussed at the meeting of the American Association for Cancer Research in Washington, D.C., which were considered as genuine breakthroughs in colon cancer treatment and prevention. The first one considered was the biologic panitumumab (Amgen) for extending...

  • Methods to Detect Circulating Tumor DNA May Help Early Diagnosis of Cancer. Hampton, Tracy // JAMA: Journal of the American Medical Association;11/7/2007, Vol. 298 Issue 17, p1993 

    This article reports on research being done to detect cancer through a blood test. Researchers at the American Association for Cancer Research discussed several studies that have been able to detect tumor-specific DNA in the blood during a conference. Circulating tumor DNA is released when...

  • Weight Gain Raises PCa Relapse Risk. Schieszer, John // Renal & Urology News;May2010, Vol. 9 Issue 5, p1 

    The article discusses the result of the study presented at the 101st Annual Meeting of the American Association for Cancer Research which reveals that weight gain in the five years before and one year after radical prostatectomy for prostate cancer could increase the risk of disease recurrence.

  • AACR inaugurates new presidential leadership.  // Hem/Onc Today;5/25/2009, Vol. 10 Issue 10, p72 

    The article announces the election of Tyler Jacks as president of the American Association for Cancer Research (AACR) for 2009.

  • Cancer journal focuses on research. Comer, Ben // Medical Marketing & Media;Dec2010, Vol. 45 Issue 12, p20 

    The article provides, brief information on the new journal "Cancer Discovery" from the American Association for Cancer Research (ACCR).

  • 2nd AACR Conference on Frontiers in Basic Cancer Research.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p390 

    The article offers information on the Second American Association for Cancer Research (AACR) Conference on Frontiers in Basic Cancer Research to be held in San Francisco, California on September 14-18, 2011.

  • ArQule Announces Presentations at AACR 102nd Annual Meeting.  // Biomedical Market Newsletter;5/21/2011, p612 

    The article offers information on the 102nd Annual Meeting of the American Association for Cancer Research (AACR) to be held in Orlando, Florida from April 2 to 6, 2011.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics